Energy Metabolites as Biomarkers in Ischemic and Dilated Cardiomyopathy

With more than 25 million people affected, heart failure (HF) is a global threat. As energy production pathways are known to play a pivotal role in HF, we sought here to identify key metabolic changes in ischemic- and non-ischemic HF by using a multi-OMICS approach. Serum metabolites and mRNAseq and...

Descripción completa

Detalles Bibliográficos
Autores principales: Haas, Jan, Frese, Karen S., Sedaghat-Hamedani, Farbod, Kayvanpour, Elham, Tappu, Rewati, Nietsch, Rouven, Tugrul, Oguz Firat, Wisdom, Michael, Dietrich, Carsten, Amr, Ali, Weis, Tanja, Niederdränk, Torsten, Murphy, Michael P., Krieg, Thomas, Dörr, Marcus, Völker, Uwe, Fielitz, Jens, Frey, Norbert, Felix, Stephan B., Keller, Andreas, Katus, Hugo A., Meder, Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923201/
https://www.ncbi.nlm.nih.gov/pubmed/33670449
http://dx.doi.org/10.3390/ijms22041999

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923201/
https://www.ncbi.nlm.nih.gov/pubmed/33670449
http://dx.doi.org/10.3390/ijms22041999

Ejemplares similares